Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

0.78
Delayed Data
As of Mar 04
 +0.0048 / +0.62%
Today’s Change
0.65
Today|||52-Week Range
1.52
+11.43%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Operating ActivitiesNet Income / Starting Line---11.3M-6.2M-9.5M
 
 
 
 
Depreciation--45.1K42.4K37.1K
 
 
 
 
Total Other Cash Flow---4.1M-246.1K1.7M
 
 
 
 
Funds From Operations---15.4M-6.4M-7.8M
 
 
 
 
Funds From/For Other Operating Expenses--116.5K189.2K181.8K
 
 
 
 
Net Cash Flow - Operating Activities-7.0M-15.5M-6.6M-8.0M
 
 
 
 
 
 
InvestingIncrease In Investments---8.0M0.000.00
 
 
Decrease In Investments--8.5M1.9M0.00
 
 
 
Capital Expenditures-5.2K-16.0K0.00-50.1K
 
 
 
 
Other Investing - Uses---1.0M0.000.00
 
 
Other Investing - Sources--0.00340.0K895.7K
 
 
 
Net Cash Flow Investing-5.3K-545.9K2.2M845.5K
 
 
 
 
 
 
FinancingShort Term Borrowings--0.000.000.00--
Long Term Borrowings--0.000.000.00--
Long Term Debt Reduction--0.000.000.00--
Net Proceeds Stock Sale--13.6M7.1M12.3M
 
 
 
 
Common Preferred Redeemed--0.000.000.00--
Common Dividends--0.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing--0.00926.0K0.00
 
 
Other Uses - Financing--0.000.000.00--
Net Cash Flow - Financing0.0013.6M8.1M12.3M
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----0.000.00--
 
Net Change In Cash-7.0M-2.5M3.6M5.2M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account